| 481 | GRADY, CLEVELANDPHILADELPHIA, PA · 19104 | PRICING/REIMBURSEMENT · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-21 | $10 | Primary (P) | Filing 1926331FEC filing ↗ |
| 482 | SPIES, CHRISTINA MARIEDURHAM, NC · 27709 | RX ACCOUNT MANAGEMENT ONCOLOGY · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-21 | $10 | Primary (P) | Filing 1926331FEC filing ↗ |
| 483 | LONG, CYNTHIA M.DURHAM, NC · 27709 | RX ACCOUNT MANAGEMENT RESP BIOLOGICS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-21 | $10 | Primary (P) | Filing 1926331FEC filing ↗ |
| 484 | GLAUNERT, KEVIN J.DURHAM, NC · 27709 | SR. SPECIALTY ACCOUNT SPECIALIST · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-21 | $10 | Primary (P) | Filing 1926331FEC filing ↗ |
| 485 | RIVERA, VICENTE S.DURHAM, NC · 27709 | SR. VACCINE ACCT EXECUTIVE · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-21 | $10 | Primary (P) | Filing 1926331FEC filing ↗ |
| 486 | TURNER, TALBERTDURHAM, NC · 27709 | DISTRICT SALES MGR · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-21 | $10 | Primary (P) | Filing 1926331FEC filing ↗ |
| 487 | KARSAY, STEPHANIEDURHAM, NC · 27709 | RX ACCOUNT MANAGEMENT RESP BIOLOGICS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-21 | $10 | Primary (P) | Filing 1926331FEC filing ↗ |
| 488 | BOKER, ROBERT A.DURHAM, NC · 27709 | SR SALES SPEC PHARMA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-21 | $10 | Primary (P) | Filing 1926331FEC filing ↗ |
| 489 | LAMB, MICHAEL K.DURHAM, NC · 27709 | SR SALES SPEC PHARMA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-21 | $10 | Primary (P) | Filing 1926331FEC filing ↗ |
| 490 | WOLFF, KEITH M.DURHAM, NC · 27709 | SR. SPECIALTY ACCOUNT SPECIALIST · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-21 | $10 | Primary (P) | Filing 1926331FEC filing ↗ |
| 491 | BARGO, JEFFREY REEDDURHAM, NC · 27709 | SR. ACCT SPEC, VACCINES · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-21 | $10 | Primary (P) | Filing 1926331FEC filing ↗ |
| 492 | HARRIS, GERI ADURHAM, NC · 27701 | EXECUTIVE DIRECTOR, TRANSFORMATION, ST · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-21 | $10 | Primary (P) | Filing 1926331FEC filing ↗ |
| 493 | MCCANN, EMILY SUZANNEDURHAM, NC · 27709 | SR ACCT SPEC, VIIV · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-21 | $10 | Primary (P) | Filing 1926331FEC filing ↗ |
| 494 | DELK, DEBBIE TAYLORDURHAM, NC · 27709 | VACCINE KEY ACCT LEAD · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2025-10-21 | $10 | Primary (P) | Filing 1926331FEC filing ↗ |
| 495 | DEMELIA, HEATHERNORTH ATTLEBORO, MA · 02760 | CLINICAL RESEARCH ASSOCIATE · GLAXOSMITHKLINE | GALLEGO FOR ARIZONAC00558627 | 2025-10-20 | $10 | Primary 2030 (P2030) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1938625FEC filing ↗ |
| 496 | DEMELIA, HEATHERNORTH ATTLEBORO, MA · 02760 | CLINICAL RESEARCH ASSOCIATE · GLAXOSMITHKLINE | JON OSSOFF FOR SENATEC00718866 | 2025-10-19 | $10 | Primary 2026 (P2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1943025FEC filing ↗ |
| 497 | DEMELIA, HEATHERNORTH ATTLEBORO, MA · 02760 | CLINICAL RESEARCH ASSOCIATE · GLAXOSMITHKLINE | MOVEON.ORG POLITICAL ACTIONC00341396 | 2025-10-19 | $10 | Primary (P) | Filing 1956023 · amendedFEC filing ↗ |
| 498 | DEMELIA, HEATHERNORTH ATTLEBORO, MA · 02760 | CLINICAL RESEARCH ASSOCIATE · GLAXOSMITHKLINE | GALLEGO FOR ARIZONAC00558627 | 2025-10-19 | $10 | Primary 2030 (P2030) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1938625FEC filing ↗ |
| 499 | DEMELIA, HEATHERNORTH ATTLEBORO, MA · 02760 | CLINICAL RESEARCH ASSOCIATE · GLAXOSMITHKLINE | MARK KELLY FOR SENATEC00696526 | 2025-10-15 | $10 | Primary 2028 (P2028) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1941700FEC filing ↗ |
| 500 | DEMELIA, HEATHERNORTH ATTLEBORO, MA · 02760 | CLINICAL RESEARCH ASSOCIATE · GLAXOSMITHKLINE | JON OSSOFF FOR SENATEC00718866 | 2025-10-12 | $10 | Primary 2026 (P2026) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1943025FEC filing ↗ |